faculty photo

Kevin G. Lynch

Associate Professor of Biostatistics in Psychiatry at the Hospital of the University of Pennsylvania and the Children's Hospital of Philadelphia
Department: Psychiatry

Contact information
3535 Market Street, #5099
Philadelphia, PA 19104
Office: 215-746-7707
B.Sc. ((Mathematics))
University College, Galway, Ireland , 1988.
M.Sc. ( (Mathematics and Statistics))
University College, Galway, Ireland , 1989.
M.A. ((Statistics))
Yale University , 1990.
Ph.D ((Statistics))
Yale University , 1997.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise


Selected Publications

Zhenhao Shi, An-Li Wang, James H. Padley, Catherine A. Aronowitz, Victoria P. Fairchild, Kevin G. Lynch, James Loughead, Daniel D. Langleben: Addicted to Green: Specific Priming Effect of Menthol Cigarette Packages on Brain Response to Smoking Cues in Menthol Cigarette Smokers. Tobacco Control 32: e45-e52, 2023.

Bhattacharya I, Ertefaie A, Lynch KG, McKay JR, Wilson A, and Johnson BA: A non-parametric Bayesian approach for adjusting partial compliance in sequential decision making. Statistics in Medicine 42(15): 2661-2691, 2023.

Anderson G, Ramsey CM, Lynch KG, Gelernter J, and Oslin DW: Baseline Platelet Serotonin in a Multi-Site Treatment Study of Depression in Veterans Administration Patients: Distribution and Effects of Demographic Variables and Serotonin Reuptake Inhibitors. Journal of Affective Disorders 327: 368-377, 2023.

Shi Z, Wang A-L, Padley JH, Aronowitz CA, Fairchild VP, Lynch KG, Loughead J, & Langleben DD: Effects of emotional arousal on the neural impact and behavioral efficacy of cigarette graphic warning labels. Addiction 118(5): 914-924, 2023.

Shi Z, Li X, Byanyima J, O’Brien CP, Childress AR, Lynch KG, Loughead J, Wiers CE, and Langleben DD: Effects of smoking severity on brain gray matter volume in opioid use disorder – a voxel-based morphometry study. American Journal of Drug and Alcohol Abuse 2023.

Oslin DW, Lynch KG, Shih M-C, for PRIME CARE study: The Utility of Pharmacogenetic Testing for the Treatment of Major Depression: The PRIME Care Randomized Clinical Trial. JAMA 328(2): 151-161, 2022.

Seneviratne C, Gorelick DA, Lynch KG, Brown C, Romer D, Pond T, Kampman K, and Kranzler HR: A Randomized, Double-Blind, Placebo-Controlled, Pharmacogenetic Study of Ondansetron for Treating Alcohol Use Disorder. Alcoholism: Clinical and Experimental Research 46(10): 1900-1912, 2022.

JR McKay, DH Gustafson, M Ivey, F McTavish, K Pe-Romashko, B Curtis, T Thomas, DW Oslin, D Polsky, A Quanbeck, and KG Lynch: Efficacy of Telephone and Automated Smartphone Remote Continuing Care for Alcohol Use Disorder. Addiction 117(5): 1326-1337, 2022.

Artman WJ, Ashkan Ertefaie A, Lynch KG, McKay JR, and Johnson BA: Bayesian set of best dynamic treatment regimes: construction and sample size calculation for SMARTs with binary outcomes. Statistics in Medicine 41(9): 1688-1708, 2022.

Lynch KG, Plebani J, Spratt K, Morales M, Tamminga M, Feibush P, and Kampman KM: Varenicline for the treatment of Cocaine Use Disorder. Journal of Addiction Medicine 16(2): 157-163, 2022.

back to top
Last updated: 07/25/2023
The Trustees of the University of Pennsylvania
Back to Top